Nova Eye Medical Limited
ELXMF
$0.00
-$0.10-98.10%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.31M | 20.04M | 18.90M | 18.01M | 17.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.31M | 20.04M | 18.90M | 18.01M | 17.22M |
| Cost of Revenue | 7.08M | 6.87M | 6.70M | 5.86M | 5.06M |
| Gross Profit | 14.23M | 13.17M | 12.20M | 12.15M | 12.17M |
| SG&A Expenses | 13.46M | 13.04M | 12.71M | 12.35M | 12.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.29M | 3.25M | 3.24M | 3.30M | 3.38M |
| Total Operating Expenses | 25.87M | 25.21M | 24.74M | 23.79M | 22.96M |
| Operating Income | -4.56M | -5.17M | -5.84M | -5.78M | -5.74M |
| Income Before Tax | -4.53M | -5.18M | -5.89M | -5.76M | -5.65M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.53 | -5.18 | -5.89 | -5.76 | -5.65 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.53M | -5.18M | -5.89M | -5.76M | -5.65M |
| EBIT | -4.56M | -5.17M | -5.84M | -5.78M | -5.74M |
| EBITDA | -3.17M | -3.76M | -4.40M | -4.09M | -3.79M |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 1.10B | 1.04B | 989.34M | 941.80M | 894.27M |
| Average Diluted Shares Outstanding | 1.10B | 1.04B | 989.34M | 941.80M | 894.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |